रिसर्च धारा वेबसाइट

Publications

1. Kante B, Vuyyuru SK, Gupta R, Dwivedi T, Kumar P, Mundhra S, Golla R, Virmani S, Verma M, Makharia G, Ahuja V, Kedia S. High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India. Indian J Gastroenterol. 2023 Feb 4:1–9. doi:10.1007/s12664-022-01310-y.

2. Madan M, Shareef I, Raja A, Dwivedi T, Mittal S, Sahoo B, et al. Covid-19 presenting as isolated severe thrombocytopenia in an HIV-lymphoma survivor. Natl Med J India. 2022 Jul-Aug;35(4):235-236. doi: 10.25259/NMJI_477_21.

3. Sagiraju HKR, Elavarasi A, Gupta N, Garg RK, Paul SS, Vig S, Sirohiya P, Ratre B, Garg R, Pandit A, Singh R, Kumar B, Meena VP, Wig N, Mittal S, Pahuja S, Madan K, Das N, Dwivedi T, Gupta R, Wundavalli L, Singh AR, Singh S, Mishra A, Pandey M, Matharoo KS, Kumar S, Mohan A, Guleria R, Bhatnagar S. The Effectiveness of SARS-CoV-2 Vaccination in Preventing Severe Illness and Death - Real-world Data from a Cohort of Patients Hospitalized with COVID-19. Indian J Community Med. 2022 Oct-Dec;47(4):510-516. doi: 10.4103/ijcm.ijcm_1388_21.

4. Ghati N, Bhatnagar S, Mahendran M, Thakur A, Prasad K, Kumar D, Dwivedi T, Mani K, Tiwari P, Gupta R, Mohan A, Saxena A, Guleria R, Deepti S. Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial). BMC Infect Dis. 2022 Jul 9;22(1):606. doi: 10.1186/s12879-022-07570-5.

5. Ghosh T, Dwivedi T, Agarwal H, Iyer H, Tiwari P, Mittal S, Gupta R, Bhatnagar S, Vig S, Mohan A. Impact of various hematological and biochemical parameters on mortality in coronavirus disease 2019 (COVID-19): A single-center study from North India. Lung India. 2022 May-Jun;39(3):230-233. doi: 10.4103/lungindia.lungindia_480_21.

6. Sirohiya P, Elavarasi A, Sagiraju HKR, Baruah M, Gupta N, Garg RK, Paul SS, Ratre BK, Singh R, Kumar B, Vig S, Pandit A, Kumar A, Garg R, Meena VP, Mittal S, Pahuja S, Das N, Dwivedi T, Gupta R, Kumar S, Pandey M, Mishra A, Matharoo KS, Mohan A, Guleria R, Bhatnagar S. Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study. Lung India. 2022 May-Jun;39(3):247-253. doi: 10.4103/lungindia.lungindia_601_21.

7. Elavarasi A, Raju Sagiraju HK, Garg RK, Ratre B, Sirohiya P, Gupta N, Garg R, Pandit A, Vig S, Singh R, Kumar B, Meena VP, Wig N, Mittal S, Pahuja S, Madan K, Guleria R, Mohan A, Dwivedi T, Gupta R, Vidyarthi AJ, Chaudhry R, Das A, Wundavalli L, Singh AR, Singh S, Kumar S, Pandey M, Mishra A, Matharoo KS, Bhatnagar S. Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort study. Lung India. 2022 Jan-Feb;39(1):16-26. doi: 10.4103/lungindia.lungindia_493_21.

8. Gupta AK, Ramachandran M, Gupta A, Meena JP, Dwivedi T, Bala K, Kanga U, Singh U, Gupta R, Seth R. Allogeneic hematopoietic stem cell transplant after COVID-19 infection and its effect on the antibody titers to SARS-CoV-2. Pediatr Transplant. 2022 Mar;26(2):e14175. doi: 10.1111/petr.14175.

9. Batra G, Murugesan DR, Chattopadhyay S, Mehdi F, Ayushi, Gosain M, Singh S, Das SJ, Deshpande S, Bhattacharya J, Pandey AK, Jha S, Goswami S, Das A, Dwivedi T, Sharma N, Kumar S, Sharma P, Kapoor S, Kshetrapal P, Wadhwa N, Thiruvengadam R, Kumar R, Gupta R, Garg PK, Bhatnagar S, DBT Consortium for COVID-19 Research. Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination. medRxiv 2022.02.23.22271381; doi: https://doi.org/10.1101/2022.02.23.22271381. [Preprint].

10. Madan M, Baldwa B, Raja A, Tyagi R, Dwivedi T, Mohan A, Mittal S, Madan K, Hadda V, Tiwari P, Guleria R. Impact of Latent Tuberculosis on Severity and Outcomes in Admitted COVID-19 Patients. Cureus. 2021 Nov 25;13(11):e19882. doi:10.7759/cureus.19882.

11. Gupta R, Dwivedi T, Gajendra S, Sahoo B, Gupta SK, Vikas H, Singh AR, Mohan A, Bhatnagar S, Singh S, Wundavalli L, Guleria R. Authors' response. Indian J Med Res. 2021 May;153(5&6):565-567. doi: 10.4103/0971-5916.323967.

12. Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R. Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial. J Infect Chemother. 2021 Dec;27(12):1743-1749. doi: 10.1016/j.jiac.2021.08.021.

13. Gupta AK, Ramachandran M, Meena JP, Dwivedi T, Singh U, Gupta R, Seth R. Robust and sustained antibody response to SARS-CoV-2 in a child pre and post autologous hematopoietic stem cell transplant. Pediatr Blood Cancer. 2021 May;68(5):e28848. doi:10.1002/pbc.28848.

14. Gupta R, Dwivedi T, Gajendra S, Sahoo B, Gupta SK, Vikas H, Singh AR, Mohan A, Bhatnagar S, Singh S, Wundavalli L, Guleria R. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India. Indian J Med Res. 2021 Jan & Feb;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.

15. Ghati N, Roy A, Bhatnagar S, Bhati S, Bhushan S, Mahendran M, Thakur A, Tiwari P, Dwivedi T, Mani K, Gupta R, Mohan A, Garg R, Saxena A, Guleria R, Deepti S. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 30;21(1):902. doi: 10.1186/s13063-020-04840-y.

16. Prakash S, Kumar BK, Dwivedi T, Sankar J. Multisystem inflammatory syndrome in children: A case report from India. J Pediatr Crit Care 2020;7:349-51. doi: 10.4103/JPCC.JPCC_126_20.

17. Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, Pahuja S, Garg R, Gupta N, Sahoo B, Gupta R, Meena VP, Vig S, Pandit A, Mittal S, Madan K, Hadda V, Dwivedi T, Choudhary A, Brijwal M, Soneja M, Guleria R, Ratre B, Kumar B, Bhopale S, Panda S, Singh AR, Singh S, Wundavalli L. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):61-69. doi: 10.4103/ijmr.IJMR_1788_20.

Hospital Services

Presently Laboratory Oncology Unit, NCI caters its services round the clock via Robotic Core Clinical Laboratory, located at 1st Floor, Diagnostic Block, NCI-AIIMS, Jhajjar [Extn: 4030, 4689 (sample receiving area)].

Laboratory Oncology Unit, NCI also handles following Blood Collection Centres

1. Blood Collection Centre, Ground Floor, OPD Block, NCI-AIIMS, Jhajjar (Extn: 4058).

Timings: Monday-Friday: 8am -4pm

Saturday: 8am-1pm

Closed: Sunday & GH

2. Blood Collection Centre, Room No: 63, Ground Floor, Outreach OPD, Badsa, Jhajjar (Extn No:3122).

Timings: Monday-Friday: 9am -1pm

Saturday: 9am-1pm

Closed: Sunday & GH

Research

In addition to clinical services, the Laboratory Oncology Unit, NCI-AIIMS has been actively participating in academic and various intra and interdepartmental research projects.